Waystar Holding Corp. (NASDAQ: WAY) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $5.3B. The Maz Rating grades it against the other companies in its sector.
Waystar Holding Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $27.67, Waystar Holding Corp. trades at 39.8x trailing earnings, 4.2x sales and 1.3x book value, with an EV/EBITDA of 15.3. Over the last twelve months it generated about $1.3B of revenue and $134M of net income. It runs a gross margin of 69.4%, an operating margin of 21.9% and a net margin of 10.7%. It shows return on equity of 3.4%, return on invested capital of 3.4% and a free cash flow yield of 5.0%. On the balance sheet: a debt-to-equity ratio of 0.37 and a current ratio of 2.10. Over the past 52 weeks the share price ranged from $17.26 to $37.51, with a beta of 0.07.
Waystar Holding Corp. does not currently pay a dividend.
19 Wall Street analyst ratings cover the stock: 1 Strong Buy, 17 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of September 2026, Waystar Holding Corp. (WAY) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 28.8% / 30% · (Cash+Inv) / Mkt Cap (36m) 5.45% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 28.8% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 5.45% / 33% · Receivables / Mkt Cap (36m) 3.68% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 28.8% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 5.45% / 33.33% · Receivables / Mkt Cap (24m) 3.68% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 25.1% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 3.05% / 33.33% · Receivables / Avg Assets (4Q) 3.11% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 24.7% / 33.33% · (Cash+ST Inv) / Total Assets 4.68% / 33.33% · (Cash+Recv) / Total Assets 7.83% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
Yes. As of September 2026, Waystar Holding Corp. (WAY) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Waystar Holding Corp. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Waystar Holding Corp. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.